Use of superoxide dismutase and catalase producing lactic acid bacteria in TNBS induced Crohn's disease in mice

Journal of Biotechnology

Volumn 151, Issue 3, 2011, Pages 287-293

  LeBlanc, Jean Guy ^a   del Carmen, Silvina ^a   Miyoshi, Anderson ^b   Azevedo, Vasco ^b   Sesma, Fernando ^a   Langella, Philippe ^c   Bermúdez Humarán, Luis G ^c   Watterlot, Laurie ^c   Perdigon, Gabriela ^a,d   de Moreno de LeBlanc, Alejandra ^a  

^a CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UMR1319 MICALIS   (France)

^d UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

Author keywords

Intestinal inflammation; Lactic acid bacteria; Superoxide dismutase

Indexed keywords

ANTIOXIDANTS; BACTERIA; DISEASES; LABORATORIES; LACTIC ACID; MAMMALS; PATHOLOGY;

ANTI-INFLAMMATORY EFFECTS; ENZYMATIC ACTIVITIES; INTESTINAL INFLAMMATION; LACTIC ACID BACTERIA; LACTOBACILLUS CASEI; REACTIVE OXYGEN SPECIES; SUPER OXIDE DISMUTASE; SUPEROXIDE DISMUTASES;

ENZYMES;

CATALASE; PROBIOTIC AGENT; SUPEROXIDE DISMUTASE; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; BODY WEIGHT; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE RELEASE; ENZYME ACTIVITY; FEMALE; HISTOLOGY; INTESTINE FLUID; LACTIC ACID BACTERIUM; LACTOBACILLUS CASEI; MORPHOLOGY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROPHYLAXIS; SURVIVAL;

ANIMALIA; BACTERIA (MICROORGANISMS); LACTOBACILLUS CASEI; MURINAE; MUS;

EID: 79151475419     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2010.11.008     Document Type: Article

References (30)

1. Aebi H. Catalase in vitro. Methods Enzymol. 1984, 105:121-126.
2. Ameho C.K., Adjei A.A., Harrison E.K., Takeshita K., Morioka T., Arakaki Y., Ito E., Suzuki I., Kulkarni A.D., Kawajiri A., Yamamoto S. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis. Gut 1997, 41:487-493.
3. Baumgart D.C., Sandborn W.J. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007, 369:1641-1657.
4. Beauchamp C., Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal. Biochem. 1971, 44:276-287.
5. Beers R.F., Sizer I.W. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem. 1952, 195:133-140.
6. Berlett B.S., Stadtman E.R. Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 1997, 272:20313-20316.
7. Bradford M.M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye-binding. Anal. Biochem. 1976, 72:248-254.
8. Carroll I.M., Andrus J.M., Bruno-Barcena J.M., Klaenhammer T.R., Hassan H.M., Threadgill D.S. Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 293:G729-G738.
9. de Moreno de LeBlanc A., Chaves S., Perdigon G. Effect of yoghhurt on the cytokine profile using a murine model of intestinal inflammation. Eur. J. Inflamm. 2009, 7:97-109.
10. de Moreno de LeBlanc A., LeBlanc J.G., Perdigon G., Miyoshi A., Langella P., Azevedo V., Sesma F. Oral administration of a catalase-producing Lactococcus lactis can prevent a chemically induced colon cancer in mice. J. Med. Microbiol. 2008, 57:100-105.
11. de Moreno de LeBlanc A., Matar C., Perdigon G. The application of probiotics in cancer. Br. J. Nutr. 2007, 98(Suppl. 1):S105-S110.
12. de Moreno de LeBlanc A., Perdigon G. The application of probiotic fermented milks in cancer and intestinal inflammation. Proc. Nutr. Soc. 2010, 69:421-428.
13. Elson C.O., Weaver C.T. Experimental mouse models of inflammatory bowel disease: new insights into pathogenic mechanisms. Inflammatory Bowel Disease. From Bench to Bedside 2003, 67-95. Springer Science+Business Media, Inc., New York. S.R. Targan, F. Shanahan, L.C. Karp (Eds.).
14. Foligne B., Nutten S., Grangette C., Dennin V., Goudercourt D., Poiret S., Dewulf J., Brassart D., Mercenier A., Pot B. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J. Gastroenterol. 2007, 13:236-243.
15. Fons M., Hege T., Ladire M., Raibaud P., Ducluzeau R., Maguin E. Isolation and characterization of a plasmid from Lactobacillus fermentum conferring erythromycin resistance. Plasmid 1997, 37:199-203.
16. Galdeano C.M., de Moreno de LeBlanc A., Vinderola G., Bonet M.E., Perdigon G. Proposed model: mechanisms of immunomodulation induced by probiotic bacteria. Clin. Vaccine Immunol. 2007, 14:485-492.
17. Han W., Mercenier A., Ait-Belgnaoui A., Pavan S., Lamine F., van S., Kleerebezem I.I., Salvador-Cartier M., Hisbergues C., Bueno M., Theodorou L., Fioramonti V.J. Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase. Inflamm. Bowel Dis. 2006, 12:1044-1052.
18. Hoffmann J.C., Pawlowski N.N., Kuhl A.A., Hohne W., Zeitz M. Animal models of inflammatory bowel disease: an overview. Pathobiology 2002, 70:121-130.
19. LeBlanc J.G., Garro M.S., Savoy de Giori G., Font de Valdez G. A novel functional soy-based food fermented by lactic acid bacteria: effect of heat treatment. J. Food Sci. 2004, 69:M246-M250.
20. LeBlanc J.G., Ledue-Clier F., Bensaada M., de Giori G.S., Guerekobaya T., Sesma F., Juillard V., Rabot S., Piard J.C. Ability of Lactobacillus fermentum to overcome host alpha-galactosidase deficiency, as evidenced by reduction of hydrogen excretion in rats consuming soya alpha-galacto-oligosaccharides. BMC Microbiol. 2008, 8:1-9.
21. Miyoshi A., Bermudez-Humaran L., Pacheco de Azevedo M., Langella P., Azevedo V. Lactic Acid Bacteria as Live Vectors: Heterologous Protein Production and Delivery Systems. Biotechnology of Lactic Acid Bacteria Novel Applications. 2010, 161-176. Blackwell Publishing, Ames, Iowa, USA. F. Mozzi, R. Raya, G. Vignolo (Eds.).
22. Nishikawa M., Tamada A., Hyoudou K., Umeyama Y., Takahashi Y., Kobayashi Y., Kumai H., Ishida E., Staud F., Yabe Y., Takakura Y., Yamashita F., Hashida M. Inhibition of experimental hepatic metastasis by targeted delivery of catalase in mice. Clin. Exp. Metastasis 2004, 21:213-221.
23. Nouaille S., Ribeiro L.A., Miyoshi A., Pontes D., Le Loir Y., Oliveira S.C., Langella P., Azevedo V. Heterologous protein production and delivery systems for Lactococcus lactis. Genet. Mol. Res. 2003, 2:102-111.
24. Podolsky D.K. Inflammatory bowel disease. New Engl. J. Med. 2002, 347:417-429.
25. Rochat T., Bermudez-Humaran L., Gratadoux J.J., Fourage C., Hoebler C., Corthier G., Langella P. Anti-inflammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependant catalase on DSS-induced colitis in mice. Microb. Cell Fact. 2007, 6:1-10.
26. 2 and protection of Lactobacillus bulgaricus from oxidative stress in milk. Appl. Environ. Microbiol. 2006, 72:5143-5149.
27. Sainte-Marie G. A paraffin embedding technique for studies employing immunofluorescence. J. Histochem. Cytochem. 1962, 10:150-156.
28. Segui J., Gironella M., Sans M., Granell S., Gil F., Gimeno M., Coronel P., Pique J.M., Panes J. Superoxide dismutase ameliorates TNBS-induced colitis by reducing oxidative stress, adhesion molecule expression, and leukocyte recruitment into the inflamed intestine. J. Leukoc. Biol. 2004, 76:537-544.
29. Turrens J.F., Crapo J.D., Freeman B.A. Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. J. Clin. Invest. 1984, 73:87-95.
30. Watterlot L., Rochat T., Sokol H., Cherbuy C., Bouloufa I., Lefevre F., Gratadoux J.J., Honvo-Hueto E., Chilmonczyk S., Blugeon S., Corthier G., Langella P., Bermudez-Humaran L.G. Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice. Int. J. Food Microbiol. 2010, 144:35-41.